BPA Call W81XWH19A0008-HT942524F0101

Award Date 5/1/24
Potential Completion Date 5/1/24
Potential Value $398K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, with a potential value of $186,784.00. The contract is for the APTIMA HIV-1 QUANT DX ASSAY, a molecular diagnostic testing system for HIV-1, to be performed at Gen-Probe's facility in Silver Spring, MD. The award has no set-aside designation and is set to be completed by August 25, 2023. Gen-Probe has a history of providing various...
This federal contract award is for the APTIMA HIV-1, PRD-03565 product from Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price type and a ceiling value of $112,672.00. The contract does not have a set-aside designation and is set to be completed by July 7, 2023. Gen-Probe Incorporated has held several federal...
This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, to provide reagents and supplies for infectious disease and anatomic pathology. The contract has a ceiling value of $478,790.58 and a period of performance through May 31, 2025. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases such...
This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The $650,000 contract is for reagents rental to support the agency's diagnostic testing requirements. The award is not set aside and is part of a larger indefinite delivery vehicle established by DHA in January 2022 with a $15 million ceiling for COVID-19 testing services and supplies. Gen-Probe has held numerous federal contracts...
This federal contract award was issued by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a subsidiary of Hologic, Inc. The $650,000 Blanket Purchase Agreement (BPA) Call contract is for the procurement of reagents, personnel, and consumables. The contract has a firm fixed price and an ultimate completion date of September 30, 2015. This contract supports the DHA's healthcare operations and pandemic response efforts by providing critical molecular diagnostic testing products,...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of REAGENTS SUPPLIES. The contract has a potential value of $559,125.00 and a completion date of March 31, 2018. There is no set-aside designation mentioned for this award. Gen-Probe Incorporated has previously provided a variety of medical diagnostic tests and equipment, including COVID-19 assays, to government agencies...
This contract is a Blanket Purchase Agreement (BPA) Call awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of reagents. The contract has a potential value of $381,350.00 and a completion date of December 18, 2019. It is a Firm Fixed Price contract with no set-aside designation. Gen-Probe Incorporated has held several federal Indefinite Delivery Contracts to provide COVID-19 assays, testing services and supplies, and broader medical...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of standard testing supplies. The contract has a potential value of $354,575.00 and a completion date of September 30, 2020. Gen-Probe Incorporated has a history of providing a variety of infectious disease testing products and services to federal agencies, including the Defense Health Agency, Department of Veterans Affairs,...
The Department of the Army Medical Command awarded a firm-fixed-price BPA call order to Gen-Probe Incorporated, a medical diagnostics company, in the amount of $302,160.00 to provide supplies for HIV-1 and hepatitis C virus testing in support of the Walter Reed Army Institute of Research (WRAIR). This contract is not set aside. Gen-Probe Incorporated has previously been awarded other federal contracts by agencies such as the Defense Health Agency, Department of Veterans Affairs, and Department...
This federal contract award is for the provision of KITE, APTIMA AUTO DETEC RGT, COLLECT KIT, VAGINA SWAB AND ETC. by Gen-Probe Incorporated, a medical diagnostics company, to the Defense Health Agency. The contract has a potential value of $650,000.00 and was awarded on September 27, 2017 with a completion date of September 30, 2018. The contract is a Blanket Purchase Agreement (BPA) call and is priced on a Firm Fixed Price basis. The place of performance is Bethesda, MD. This award is not...
  • W81XWH19A0008
    Blanket Purchase Agreement
  • W81XWH19A0008-HT942524F0101
    BPA Call

This is a firm-fixed-price BPA call contract awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of supplies and consumables for HIV-1 assays. The contract has a total ceiling value of $397,568.00 and a performance period ending on May 1, 2024. The contract does not have a set-aside designation. Gen-Probe Incorporated has a history of providing various medical diagnostic tests and equipment, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans Affairs, and Department of the Navy.

Generated 7/8/24, 9:01 AM